Ledger.Open graph →
SEC Form D · filed September 16, 2024

STAQ Pharma, Inc

Offering
$30.0M
Sold
$11.4M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
DENVER, CO
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (25)

Dan M. Seff · Denver, CODirectorJoseph W. Bagan · Denver, COExec · DirectorChet M. Kaczor · Denver, CODirectorJeffrey L. Hval · Denver, COExec · DirectorScott M. Hawig · Denver, CODirectorMark M. Spiecker · Denver, COExec · DirectorCarol M. Lewis · Denver, CODirectorNora S. Coggin · St. Louis, MOExec · DirectorGhlee T. Cozad, Iii · St. Louis, MODirectorSidney M. Warsinske · seattle, WADirectorJohn P. Stupp, Iii · St. Louis, MODirectorRobert M. Romero · Palo Alto, CAExec · DirectorFacundo T. Oyenard · St. Louis, MODirectorJeffrey W. Bierman · St. Louis, MOExec · DirectorBrad M. Hauert · Denver, CODirectorPaul M. Jenny · Denver, CODirectorJason Jumonville · Atlanta, GADirectorJon D. Ralph · Los Angeles, CAExec · DirectorJohn Roth · Los Angeles, CADirectorChris M. Iorillo · Los Angeles, CADirectorDavid Buck · BOISE, IDExec · DirectorKatie Vila · BOISE, IDDirectorJacob Foley · New York, NYExec · DirectorBrad M. Hauert · Denver, CODirectorPaul M. Jenny · Denver, CODirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗